Loading...

Sandoz Group AG

SDZNYPNK
Healthcare
Drug Manufacturers - Specialty & Generic
$58.61
$-0.76(-1.27%)

Sandoz Group AG (SDZNY) Financial Performance & Income Statement Overview

Access detailed quarterly and annual financial reports for Sandoz Group AG (SDZNY), covering cash flow, earnings, and balance sheets.

Revenue Growth
-8.60%
8.60%
Operating Income Growth
262.60%
262.60%
Net Income Growth
-100.00%
100.00%
Operating Cash Flow Growth
101.65%
101.65%
Operating Margin
2.96%
2.96%
Gross Margin
47.44%
47.44%
Net Profit Margin
0.00%
ROE
0.00%
ROIC
2.26%
2.26%

Sandoz Group AG (SDZNY) Income Statement & Financial Overview

Access detailed annual and quarterly income data for Sandoz Group AG SDZNY financial performance.

MetricQ4 2024Q2 2024
Revenue$4.06B$5.06B
Cost of Revenue$2.12B$2.68B
Gross Profit$1.93B$2.38B
Gross Profit Ratio$0.48$0.47
R&D Expenses$331.78M$489.00M
SG&A Expenses$896.66M$1.25B
Operating Expenses$906.64M$2.05B
Total Costs & Expenses$3.03B$4.73B
Interest Income$37.87M$0.00
Interest Expense$235.14M$0.00
Depreciation & Amortization$233.10M$209.00M
EBITDA$126.55M$541.00M
EBITDA Ratio$0.03$0.11
Operating Income$1.03B$332.00M
Operating Income Ratio$0.25$0.07
Other Income/Expenses (Net)-$1.24B-$128.00M
Income Before Tax-$213.69M$204.00M
Income Before Tax Ratio-$0.05$0.04
Income Tax Expense-$63.57M$53.00M
Net Income-$150.00M$150.00M
Net Income Ratio-$0.04$0.03
EPS-$0.35$0.35
Diluted EPS-$0.35$0.35
Weighted Avg Shares Outstanding$430.20M$430.20M
Weighted Avg Shares Outstanding (Diluted)$434.00M$432.20M

The company's financials show resilient growth, with revenue advancing from $5.06B in Q2 2024 to $4.06B in Q4 2024. Gross profit remained healthy with margins at 48% in Q4 2024 compared to 47% in Q2 2024. Operating income hit $1.03B last quarter, sustaining a consistent 25% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $126.55M. Net income dropped to -$150.00M, while earnings per share reached -$0.35. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.

Unlock 25+ Years of Financial Data

Get access to extended historical data, advanced metrics, and more with our premium plan

Frequently Asked Questions

;